|
Septum Pellucidum
|
A08.186.211.180.750.900 |
|
|
Anesthetists
|
D000072077 |
[Persons trained and certified to administer ANESTHETICS.
] |
|
Positron Emission Tomography Computed Tomography
|
D000072078 |
[An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session.
] |
|
Receptors, Corticotropin
|
D12.776.543.750.750.555.285 |
|
|
Patched Receptors
|
D000072079 |
[A family of 12-pass transmembrane proteins originally identified in Drosophila that are receptors for HEDGEHOG PROTEINS. They have important roles in regulating CELL PROLIFERATION; CELL DIFFERENTIAION; and BODY PATTERNING and may also function as TUMOR SUPPRESSOR PROTEINS.
] |
|
Hand Transplantation
|
E04.936.450.825.500 |
|
|
Vascularized Composite Allotransplantation
|
E04.936.450.825 |
|
|
Salicylates
|
D02.241.511.390.595 |
|
|
Mucolipidoses
|
C16.320.565.202.670 |
|
|
Chewing Gum
|
D20.215.721.249.249 |
|
|
Carcinoma, Basosquamous
|
C04.557.470.200.170 |
|
|
Heart Auscultation
|
E01.370.600.060.400 |
|
|
Auscultation
|
E01.370.600.060 |
|
|
Femoral Neck Fractures
|
C26.558.276.425.500 |
|
|
Focal Adhesion Protein-Tyrosine Kinases
|
D08.811.913.696.620.682.725.049 |
|
|
GRB7 Adaptor Protein
|
D12.644.360.024.299 |
|
|
Carcinoma, Basal Cell
|
C04.557.470.200.165 |
|
|
Anesthesiologists
|
D000072080 |
[Physicians specializing in ANESTHESIOLOGY.
] |
|
Patched-1 Receptor
|
D000072081 |
[A patched receptor for several HEDGEHOG PROTEINS that associates with the SMOOTHENED RECEPTOR to modulate hedgehog signaling. It is also a TUMOR SUPPRESSOR PROTEIN; mutations in the patched-1 gene are associated with BASAL CELL NEVUS SYNDROME; SQUAMOUS CELL CARCNIOMA of the ESOPHAGUS; trichoepitheliomas, and CARCINOMA, TRANSITIONAL CELL of the URINARY BLADDER.
] |
|
Patched-2 Receptor
|
D000072082 |
[A patched receptor that may function redundantly with the PATCHED-1 RECEPTOR to modulate hedgehog signaling. It may also play a role in epidermal development and as a TUMOR SUPPRESSOR PROTEIN. Mutations in the patched-2 gene are associated with BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; and MEDULLOBLASTOMA.
] |
